Locust Walk Acquisition Corp. Contracts & Agreements

General Release of Claims, dated as of February 13, 2024, by and between eFFECTOR and Mayank Gandhi (Filed With SEC on March 26, 2024)

eFFECTOR Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on March 26, 2024)

Form of Securities Purchase Agreement (Filed With SEC on January 26, 2024)

Form of Wainwright Warrant (Filed With SEC on January 26, 2024)

Form of Common Warrant (Filed With SEC on January 26, 2024)

Form of Pre-Funded Warrant (Filed With SEC on January 26, 2024)

Form of Securities Purchase Agreement (Filed With SEC on June 8, 2023)

Form of Wainwright Warrant (Filed With SEC on June 8, 2023)

Form of Common Warrant (Filed With SEC on June 8, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 8, 2023)

Form of Securities Purchase Agreement (Filed With SEC on May 30, 2023)

Form of Wainwright Warrant (Filed With SEC on May 30, 2023)

Form of Common Warrant (Filed With SEC on May 30, 2023)

Form of Pre-Funded Warrant (Filed With SEC on May 30, 2023)

Consulting Agreement, dated April 1, 2022, by and between eFFECTOR and Premal Patel, M.D., Ph.D (Filed With SEC on August 9, 2022)

General Release of Claims, effective as of April 8, 2022, by and between eFFECTOR and Premal Patel, M.D., Ph.D (Filed With SEC on August 9, 2022)

General Release of Claims, effective as of July 22, 2022, by and between eFFECTOR and Alana McNulty (Filed With SEC on August 9, 2022)

Third Amendment to Loan and Security Agreement, dated April 28, 2022, by and among eFFECTOR and Oxford Finance LLC (Filed With SEC on May 10, 2022)

Description of Registered Securities (Filed With SEC on March 16, 2022)

Second Amendment to Loan and Security Agreement, dated February 22, 2022, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc. and Oxford Finance LLC (Filed With SEC on February 24, 2022)

Joinder and First Amendment to Loan and Security Agreement, dated September 7, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc. and Oxford... (Filed With SEC on February 24, 2022)

Registration Rights Agreement, dated January 24, 2022, between eFFECTOR and Lincoln Park Capital Fund, LLC (Filed With SEC on January 24, 2022)

Purchase Agreement, dated January 24, 2022, between eFFECTOR and Lincoln Park Capital Fund, LLC (Filed With SEC on January 24, 2022)

Commercial Lease, dated September 29, 2021, by and between North Cedros, LLC and eFFECTOR Therapeutics, Inc (Filed With SEC on November 8, 2021)

eFFECTOR Therapeutics, Inc. Non-Employee Director Compensation Program (Filed With SEC on November 8, 2021)

eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. Non-Employee Director Compensation Program (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and form of option agreement thereunder (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2021 Incentive Award Plan and Form of Stock Option Agreement thereunder (Filed With SEC on August 31, 2021)

Amended and Restated Registration Rights Agreement, dated August 25, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc., Locust Walk Sponsor,... (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. Non-Employee Director Compensation Program (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and form of option agreement thereunder (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2021 Incentive Award Plan and Form of Stock Option Agreement thereunder (Filed With SEC on August 31, 2021)

Amended and Restated Registration Rights Agreement, dated August 25, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc., Locust Walk Sponsor,... (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and form of option agreement thereunder (Filed With SEC on June 14, 2021)

Exclusive License Agreement, dated May 9, 2013, by and between eFFECTOR and the Regents of the University of California (Filed With SEC on June 14, 2021)

Research Collaboration and License Agreement, dated December 20, 2019, by and between eFFECTOR and Pfizer Inc (Filed With SEC on June 14, 2021)

Loan and Security Agreement, dated March 19, 2021, by and among eFFECTOR and Oxford Finance LLC and the other lenders party thereto (Filed With SEC on June 14, 2021)

Sublease Agreement, dated August 24, 2020, by and between eFFECTOR and Cardiff Oncology, Inc (Filed With SEC on June 14, 2021)

eFFECTOR Therapeutics, Inc. Non-Employee Director Compensation Program (Filed With SEC on June 14, 2021)

Second Amended and Restated Employment Agreement by and between Stephen T. Worland, Ph.D. and eFFECTOR, to be effective at the Closing (Filed With SEC on June 14, 2021)

Amended and Restated Employment Agreement by and between Alana McNulty and eFFECTOR, to be effective at the Closing (Filed With SEC on June 14, 2021)

Amended and Restated Employment Agreement by and between Mike Byrnes and eFFECTOR, to be effective at the Closing (Filed With SEC on June 14, 2021)

Amended and Restated Employment Agreement by and between Premal Patel and eFFECTOR, to be effective at the Closing (Filed With SEC on June 14, 2021)

Locust Walk Acquisition Corp. Description of Securities (Filed With SEC on March 29, 2021)

Registration Rights Agreement, dated January 7, 2021, between the Company and certain security holders of the Company (Filed With SEC on January 13, 2021)

Underwriting Agreement, dated January 7, 2021, between the Company and Cantor Fitzgerald & Co (Filed With SEC on January 13, 2021)

Warrant Agreement, dated January 7, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on January 13, 2021)

Letter Agreement, dated January 7, 2021, by and among the Company and certain security holders, officers and directors of the Company (Filed With SEC on January 13, 2021)

Investment Management Trust Agreement, dated January 7, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on January 13, 2021)

Unit Subscription Agreement, dated January 7, 2021, between the Company and Locust Walk Sponsor, LLC (Filed With SEC on January 13, 2021)

Administrative Services Agreement, dated January 7, 2021, between the Company and Locust Walk Sponsor, LLC (Filed With SEC on January 13, 2021)

Form of Underwriting Agreement (Filed With SEC on December 18, 2020)

Form of Administrative Services Agreement (Filed With SEC on December 18, 2020)

First Amendment to Promissory Note, dated December 7, 2020 (Filed With SEC on December 18, 2020)

Promissory Note dated October 6, 2020, for expenses prior to initial public offering expenses from Locust Walk Sponsor, LLC to Registrant (Filed With SEC on December 18, 2020)

Form of Indemnity Agreement (Filed With SEC on December 18, 2020)

Form of Letter Agreement by and between the Registrant, the Registrants security holders named therein, and the officers and directors of the Registrant (Filed With SEC on December 18, 2020)

Form of Placement Unit Subscription Agreement with Locust Walk Sponsor, LLC (Filed With SEC on December 18, 2020)

Form of Registration Rights Agreement among the Registrant and security holders (Filed With SEC on December 18, 2020)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 18, 2020)

Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on December 18, 2020)

Specimen Common Stock Certificate (Filed With SEC on December 18, 2020)

Specimen Unit Certificate (Filed With SEC on December 18, 2020)

Category

Industry

Companies

Contracts

Locust Walk Acquisition Corp. Contracts & Agreements